A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Purpose
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Conditions
- Hematologic Malignancies
- Inherited Disorders of Metabolism
- Inherited Abnormalities of Platelets
- Histiocytic Disorders
- Acute Myelogenous Leukemia (AML or ANLL)
- Acute Lymphoblastic Leukemia (ALL)
- Other Acute Leukemia
- Chronic Myelogenous Leukemia (CML)
- Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases
- Other Leukemia
- Hodgkin Lymphoma
- Non-hodgkin Lymphoma
- Multiple Myeloma/ Plasma Cell Disorder (PCD)
- Inherited Abnormalities of Erythrocyte Differentiation or Function
- Disorders of the Immune System
- Autoimmune Diseases
- Severe Aplastic Anemia
Eligibility
- Eligible Ages
- All ages
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment - Signed informed consent (and signed assent, if applicable) obtained prior to study enrollment - Pediatric and adult patients of any age
Exclusion Criteria
- Patients who are receiving only licensed CBUs - Cord blood transplant recipients at international transplant centers - Patients who are enrolled on another IND protocol to access the unlicensed CBU(s) - Patients whose selected unlicensed CBU(s) will be more than minimally manipulated
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Prospective
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Unlicensed CBU | The cohort includes recipients of any age receiving unlicensed cryopreserved cord blood units (CBUs) for designated indications. |
|
Recruiting Locations
Birmingham, Alabama 35233
Gilbert, Arizona 85234
Tucson, Arizona 85224
Little Rock, Arkansas 72202
Glendale, California 91204
La Jolla, California 92093
LaJolla, California 92037
Loma Linda, California 92350
Los Angeles, California 90095
Oakland, California 94609
Orange, California 92868
Sacramento, California 95816
San Diego, California 92123
Stanford, California 94304
Aurora, Colorado 80045
Aurora, Colorado 80045
Denver, Colorado 80218
Brandywine, Delaware 19803
Washington DC, District of Columbia 20010
Gainesville, Florida 32610
Jacksonville, Florida 32207
Miami, Florida 33155
Orlando, Florida 32804
Orlando, Florida 32804
St. Petersburg, Florida 33701
Honolulu, Hawaii 96813
Chicago, Illinois 60611
Chicago, Illinois 60612
Sunita Nathan, MD
Chicago, Illinois 60612
Chicago, Illinois 60614
Chicago, Illinois 60637
Beech Grove, Indiana 46107
Indianapolis, Indiana 46202
Iowa City, Iowa 52242
Louisville, Kentucky 40202
New Orleans, Louisiana 70118
Boston, Massachusetts 02111
Boston, Massachusetts 02215
Worcester, Massachusetts 01655
Detroit, Michigan 48201
Grand Rapids, Michigan 49503
Grand Rapids, Michigan 49503
Jackson, Mississippi 39216
St. Louis, Missouri 63104
St. Louis, Missouri 63110
St. Louis, Missouri 63110
Omaha, Nebraska 68198-2168
Hackensack, New Jersey 07601
New Brunswick, New Jersey 08901
Bronx, New York 10467
Buffalo, New York 14263
Lake Sucess, New York 11042
New Hyde, New York 11040
New York, New York 10016
New York, New York 10021
New York, New York 10032
New York, New York 10065
New York, New York 10595
Rochester, New York 14642-8704
Stony Brook, New York 11794
Charlotte, North Carolina 28203
Durham, North Carolina 27705
Akron, Ohio 44308
Cincinnati, Ohio 45229
Cleveland, Ohio 44106
Columbus, Ohio 43205
Columbus, Ohio 43210
Oklahoma City, Oklahoma 73103
Portland, Oregon 97239
Hershey, Pennsylvania 17033
Philadelphia, Pennsylvania 19104
Pittsburgh, Pennsylvania 15224
Pittsburgh, Pennsylvania 15232
Pittsburg, Pennsylvania 19104
Providence, Rhode Island 02908
Charleston, South Carolina 29425
Sioux Falls, South Dakota 57105
Memphis, Tennessee 38104
Memphis, Tennessee 38105
Dallas, Texas 75235
Fort Sam Houston, Texas 78234
Fort Worth, Texas 76104
Houston, Texas 77030
Houston, Texas 77030
San Antonio, Texas 78207
San Antonio, Texas 78229
Charlottesville, Virginia 22908
Richmond, Virginia 23227
Seattle, Washington 98109
Morgantown, West Virginia 26506-8110
Madison, Wisconsin 53792
Milwaukee, Wisconsin 53226
Milwaukee, Wisconsin 53226
More Details
- NCT ID
- NCT01351545
- Status
- Recruiting
- Sponsor
- Center for International Blood and Marrow Transplant Research
Detailed Description
Principal Investigators: The principal investigators (PIs) will be transplant physicians at all participating U.S. transplant centers. Study Design: This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications. Primary Objective: The primary objective of this study is to examine the incidence of neutrophil recovery of ≥500/mm3 after cord blood transplantation in a multi-institution setting using CBUs that are not Food and Drug Administration (FDA) licensed. Secondary Objectives: In patients receiving a non-licensed CBU: - Assess incidence of transmission of infection - Assess incidence of serious infusion reaction - Determine 1 year overall survival after cord blood transplantation - Assess cumulative incidence of acute graft vs. host disease (GVHD) grades II to IV and grades III to IV - Assess cumulative incidence of chronic GVHD - Determine platelet engraftment of >20,000 mcL and >50,000 mcL